Literature DB >> 18349436

Willingness to pay for a cure in patients with chronic gout.

Dinesh Khanna1, Mansoor Ahmed, Dustin Yontz, Shaari S Ginsburg, Joel Tsevat.   

Abstract

INTRODUCTION: Gout is a chronic painful inflammatory arthritis. The authors interviewed patients with chronic stable gout to assess their hypothetical willingness to pay (WTP) to be cured of their gout. PATIENTS AND METHODS: Patients with gout were asked how much money they would be willing to pay every month out of pocket or as a co-pay to cure their gout. To assess determinants of WTP amounts, the authors performed stepwise multivariable linear regression analysis, controlling for demographics, health status, and relative concern about gout.
RESULTS: Of the 78 patients, 70 (90%) were male, 54 (69%) were Caucasian, 21 (27%) were African American, and 32 (41%) had annual incomes < $25,000. The median WTP amount was $25 ($0, $75) per month, and the mean (s) was $52 ($74) per month (range, $0-$350); 23 (30%) patients were unwilling to pay any amount. Patients who rated their gout as their top health concern were willing to pay a median of $63 ($25, $100) per month. In multivariable analysis, gout as the top health concern, greater frequency of gouty attacks over the past 1 y, and younger age were significantly associated with WTP amounts (R(2) =0:19 ).
CONCLUSION: Many patients with chronic gout would be willing to pay money every month in perpetuity to be cured of their gout. Younger patients, patients whose main health concern is gout, and patients with frequent attacks are willing to pay the most.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349436     DOI: 10.1177/0272989X08315252

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  4 in total

1.  The disutility of chronic gout.

Authors:  Dinesh Khanna; Mansoor Ahmed; Dustin Yontz; Shaari S Ginsburg; Grace S Park; Anthony Leonard; Joel Tsevat
Journal:  Qual Life Res       Date:  2008-05-24       Impact factor: 4.147

2.  Gout disease-specific quality of life and the association with gout characteristics.

Authors:  Jan D Hirsch; Robert Terkeltaub; Dinesh Khanna; Jasvinder Singh; Andrew Sarkin; Micki Shieh; Arthur Kavanaugh; Susan J Lee
Journal:  Patient Relat Outcome Meas       Date:  2010-03-01

3.  Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.

Authors:  Casper Webers; Ivette Essers; Astrid van Tubergen; Jürgen Braun; Frank Heldmann; Xenofon Baraliakos; Annelies Boonen
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02-18       Impact factor: 4.794

4.  Assessing quality of life in older adult patients with skin disorders.

Authors:  Miranda A Farage; Kenneth W Miller; Susan N Sherman; Joel Tsevat
Journal:  Glob J Health Sci       Date:  2012-02-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.